Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

822842

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of minimum unit pricing on alcohol-related hospital admissions.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	122525
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Public Health England published an evidence review on the public health impact of alcohol and the effectiveness of policies for reducing alcohol-related harm in December 2016. The review concluded that reducing the affordability of alcohol is the most effective way of reducing alcohol harm, including hospital admissions and deaths, and targeted pricing measures are particularly effective at reducing harm in those groups most at risk.</p><p> </p><p>The review also found that targeting price increases at the cheapest alcohol is very effective and cost-effective and is able to substantially reduce harm in heavy drinkers without affecting moderate drinkers or the price of alcohol sold in pubs and bars. Modelling studies by the University of Sheffield on the impact of minimum unit price was shown to have a positive impact in closing the health inequalities gap between those in the highest and those in the lowest socioeconomic groups. These studies are available at:</p><p> </p><p><a href="https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf" target="_blank">https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf</a></p><p> </p><p>Minimum unit pricing and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 16:46:23 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill

822843

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of minimum unit pricing on the level of alcohol-related deaths.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	122526
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Public Health England published an evidence review on the public health impact of alcohol and the effectiveness of policies for reducing alcohol-related harm in December 2016. The review concluded that reducing the affordability of alcohol is the most effective way of reducing alcohol harm, including hospital admissions and deaths, and targeted pricing measures are particularly effective at reducing harm in those groups most at risk.</p><p> </p><p>The review also found that targeting price increases at the cheapest alcohol is very effective and cost-effective and is able to substantially reduce harm in heavy drinkers without affecting moderate drinkers or the price of alcohol sold in pubs and bars. Modelling studies by the University of Sheffield on the impact of minimum unit price was shown to have a positive impact in closing the health inequalities gap between those in the highest and those in the lowest socioeconomic groups. These studies are available at:</p><p> </p><p><a href="https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf" target="_blank">https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf</a></p><p> </p><p>Minimum unit pricing and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 16:46:24 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill

822940

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the take-up rate for cervical screening was in (a) the West Midlands (b) Coventry in 2017.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	122623
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>The National Health Service Cervical Screening Programme measures coverage rather than uptake rate. NHS England is responsible for monitoring the coverage rates for cervical screening in all age groups and is committed to improving coverage and reducing variation between all age groups.</p><p> </p><p>The percentage of coverage for each area requested at the end of 2016-17 is: West Midlands, 71.4%; Coventry, 70.5%.</p><p> </p><p> </p><p>Cervical cancer screening data for the West Midlands are available here:</p><p> </p><p><a href="https://digital.nhs.uk/catalogue/PUB30134" target="_blank">https://digital.nhs.uk/catalogue/PUB30134</a></p><p> </p><p>Data for Coventry are available through the Public Health England Fingertips tool:</p><p> </p><p><a href="http://fingertips.phe.org.uk/profile/cancerservices" target="_blank">http://fingertips.phe.org.uk/profile/cancerservices</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 16:44:59 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

819795

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Spondyloarthritis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what mechanisms have been put in place to identify accurately the number of individuals diagnosed with ankylosing spondylitis and psoriatic arthritis within the NHS in England.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	121867
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Improving Lives - The Work, Health and Disability Green Paper, published on 31 October 2016, sets out the Government’s commitment to work with NHS England to identify opportunities for regular collection of data about incidence, prevalence, clinical activity and outcomes of musculoskeletal (MSK) conditions and services in England. The Government’s Mandate to NHS England reiterated this commitment.</p><p> </p><p>On 30 November 2017, the Government published Improving Lives - The Future of Work, Health and Disability in response to the Green Paper. This builds on the commitment to identify opportunities for routine data collection about MSK incidence, prevalence, clinical activity, and outcomes. The report outlined that a data advisory group, led by Arthritis Research UK, has been examining the issue. On 1 December 2017, the advisory group presented its recommendations to NHS England, which is currently considering the appropriate next steps.</p><p> </p><p>Improving Lives - The Future of Work, Health and Disability can be found at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability" target="_blank">www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:07:08 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day

819799

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department uses artificial intelligence to spot breast Cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	121871
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>We are aware of a study at the Massachusetts Institute of Technology into Artificial Intelligence (AI) in diagnosing breast cancer in women. Modern digital pathology techniques have created the opportunity to produce AI-based algorithms that could provide grading of tumours and prognostic insights that are not currently available through conventional methodology. However, the future availability of any new or novel tests on the National Health Service would be subject to large scale clinical trials demonstrating the safety and efficacy of the diagnostic approach and subsequent assessments of its cost effectiveness for routine use. Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) provides authoritative, evidence-based guidance for the NHS on whether drugs and other treatments represent an effective use of NHS resources. NHS commissioners are legally required to fund drugs and treatments recommended by NICE within three months of final guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:04:56 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

819854

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Slaughterhouses: Inspections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December 2017 to Question 118905, on Slaughterhouses: Inspections, how many establishments in each group of those audit results received (a) improvement necessary and (b) urgent improvement necessary audit results.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	121926
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Due to the way the data are gathered and extracted from the system, the numbers below detail the number of audits with unsatisfactory outcomes, rather than the number of establishments with unsatisfactory outcomes. That means that one establishment might have received more than one unsatisfactory outcome during the period accounted for. The data below are for England and Wales.</p><p> </p><p>From August 2014 to December 2017- Improvement necessary</p><p> </p><p>Slaughterhouses (including slaughterhouses with co-located cutting plants and wild game establishments)</p><p>2014 – 29</p><p>2015 – 55</p><p>2016 – 45</p><p>2017 – 41</p><p> </p><p>Others (Cutting Plants)</p><p>2014 – 17</p><p>2015 – 36</p><p>2016 – 36</p><p>2017 – 39</p><p>From August 2014 to December 2017- Urgent Improvement necessary</p><p> </p><p>Slaughterhouses (including slaughterhouses with co-located cutting plants and wild game establishments)</p><p>2014 – 7</p><p>2015 – 5</p><p>2016 – 5</p><p>2017 – 7</p><p> </p><p>Others (Cutting Plants)</p><p>2014 – 1</p><p>2015 – 5</p><p>2016 – 1</p><p>2017 – 8</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:09:34 answering member 4067 label Biography information for Steve Brine
tabling member	1491 label Biography information for Kerry McCarthy

819857

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Slaughterhouses: Inspections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December 2017 to Question 118905, on Slaughterhouses: Inspections, how many (a) slaughterhouses and (b) other meat establishments have received unsatisfactory audit results in each year since 2010.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	121929
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>The Food Standards Agency audit system was updated in August 2014, changing significantly the categorisations of each question being assessed and the audit outcomes. The results presented below have been split in two sections to accommodate the differences between these two periods.</p><p> </p><p>In addition, due to the way the data are gathered and extracted from the system, the numbers below detail the number of audits with unsatisfactory outcomes, rather than the number of establishments with unsatisfactory outcomes. That means that one establishment might have received more than one unsatisfactory outcome during the period accounted for. The data below are for England and Wales.</p><p> </p><p>From 2010 to July 2014</p><p> </p><p>In this section audits leading to a re-audit within two months have been considered as unsatisfactory leading to immediate intervention being required.</p><p>Slaughterhouses (including slaughterhouses with co-located cutting plants and wild game establishments)</p><p>2010 – 11</p><p>2011 – 4</p><p>2012 – 20</p><p>2013 – 23</p><p>2014 – 8</p><p> </p><p>Others (Cutting Plants)</p><p>2010 – 4</p><p>2011 – 0</p><p>2012 – 5</p><p>2013 – 1</p><p>2014 – 2</p><p> </p><p>From August 2014 to December 2017</p><p> </p><p>In this section audits with Urgent Improvement Necessary outcome have been considered as unsatisfactory leading to immediate intervention being required.</p><p>Slaughterhouses (including slaughterhouses with co-located cutting plants and wild game establishments)</p><p>2014 – 7</p><p>2015 - 5</p><p>2016 - 5</p><p>2017 - 7</p><p> </p><p>Others (Cutting Plants)</p><p>2014 – 1</p><p>2015 - 5</p><p>2016 - 1</p><p>2017 - 8</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:34:52 answering member 4067 label Biography information for Steve Brine
tabling member	1491 label Biography information for Kerry McCarthy

819976

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prescriptions for (a) benzodiazepines, (b) z drugs and (c) antidepressants were issued in the last year.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	122048
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>The information is not available for the year requested. 2017 Prescription Cost Analysis (PCA) data will be available in March 2018. Data for 2016 is shown in the table below.</p><p><strong> </strong></p><p>Number of prescription items for benzodiazepines, z drugs and antidepressants written in the United Kingdom and dispensed in the community in England, 2016.</p><p> </p><table><tbody><tr><td><p>Group</p></td><td><p>Items</p></td></tr><tr><td><p>benzodiazepines</p></td><td><p>10,004,374</p></td></tr><tr><td><p>z drugs</p></td><td><p>6,351,983</p></td></tr><tr><td><p>antidepressant drugs BNF 4.3</p></td><td><p>64,703,568</p></td></tr></tbody></table><p>Source: PCA</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:17:14 answering member 4067 label Biography information for Steve Brine
tabling member	4436 label Biography information for Cat Smith

819978

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many licences for the manufacture or supply of (a) benzodiazepines (b) z drugs and (c) antidepressants have been issued by the Medicines and Healthcare products Regulatory Agency in the last year.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	122050
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>The numbers of licences (marketing authorisations) for the manufacture or supply of benzodiazepines z drugs and antidepressants issued by the Medicines and Healthcare products Regulatory Agency in the last year (2017) are:</p><p> </p><p>Benzodiazepines: six licences</p><p>Z-drugs: six licences</p><p>Antidepressants: 33 licences</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:15:07 answering member 4067 label Biography information for Steve Brine
tabling member	4436 label Biography information for Cat Smith

819992

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will introduce a national minor ailments scheme as part of the Pharmacy Integration Fund, and if he will make a statement.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	122064
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Minor ailment services are commissioned locally by the National Health Service according to need. The purpose of the Pharmacy Integration Fund (PhIF) is to try out and evaluate new ways of integrating pharmacists and community pharmacy into the wider health care system. National commissioning of NHS pharmaceutical services is arranged through the Community Pharmacy Contractual Framework. In December 2017, under the PhIF, NHS England commenced a pilot urgent minor illness care pathway of direct referral from NHS 111 to community pharmacy. The outcome of this pilot will inform future commissioning decisions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:11:29 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy